Association of Nrf2 polymorphism haplotypes with acute lung injury phenotypes in inbred strains of mice

Antioxidants and Redox Signaling

Volumn 22, Issue 4, 2015, Pages 325-338

  Cho, Hye Youn ^a   Jedlicka, Anne E ^b   Gladwell, Wesley ^a   Marzec, Jacqui ^a   McCaw, Zackary R ^a   Bienstock, Rachelle J ^a   Kleeberger, Steven R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR SP1; NFE2L2 PROTEIN, MOUSE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA SEQUENCE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HYPEROXIA; INBRED MOUSE STRAIN; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSACTIVATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MALE; METABOLISM; PROTEIN SECONDARY STRUCTURE;

MUS;

ACUTE LUNG INJURY; ANIMALS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HYPEROXIA; MALE; MICE; MICE, INBRED STRAINS; MODELS, MOLECULAR; NF-E2-RELATED FACTOR 2; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, SECONDARY; SEQUENCE ANALYSIS, DNA;

EID: 84921378791     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.5942     Document Type: Article

References (60)

1. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, and Lipman DJ. Gapped BLAST and PSIBLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402, 1997.
2. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Arima Y, Okubo M, Hirata I, and Nakano H. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium. Oncol Rep 19: 211-216, 2008.
3. Bowler RP, Barnes PJ, and Crapo JD. The role of oxidative stress in chronic obstructive pulmonary disease. COPD 1: 255-277, 2004.
4. Chan K, Lu R, Chang JC, and Kan YW. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci USA 93: 13943-13948, 1996.
5. Cho HY. Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2. Oxid Med Cell Longev 2013: 286524, 2013.
6. Cho HY, Jedlicka AE, Reddy SP, Kensler TW, Yamamoto M, Zhang LY, and Kleeberger S.R. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 26: 175-182, 2002.
7. Cho HY, Jedlicka AE, Reddy SP, Zhang LY, Kensler TW, and Kleeberger S.R. Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene. Am J Respir Cell Mol Biol 26: 42-51, 2002.
8. Cho HY, Morgan DL, Bauer AK, and Kleeberger S.R. Signal transduction pathways of tumor necrosis factor-mediated lung injury induced by ozone in mice. Am J Respir Crit Care Med 175: 829-839, 2007.
9. Cho HY, Reddy SP, Debiase A, Yamamoto M, and Kleeberger S.R. Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic Biol Med 38: 325-343, 2005.
10. Cho HY, Reddy SP, Yamamoto M, and Kleeberger S.R. The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J 18: 1258-1260, 2004.
11. Cho HY, van Houten B, Wang X, Miller-Degraff L, Fostel J, Gladwell W, Perrow L, Panduri V, Kobzik L, Yamamoto M, Bell DA, and Kleeberger S.R. Targeted deletion of Nrf2 impairs lung development and oxidant injury in neonatal mice. Antioxid Redox Signal 17: 1066-1082, 2012.
12. Chow CW, Herrera Abreu MT, Suzuki T, and Downey GP. Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol 29: 427-431, 2003.
13. Cordova EJ, Velazquez-Cruz R, Centeno F, Baca V, and Orozco L. The NRF2 gene variant,-653G/A, is associated with nephritis in childhood-onset systemic lupus erythematosus. Lupus 19: 1237-1242, 2010.
14. Fernandez-Fuentes N, Madrid-Aliste CJ, Rai BK, Fajardo JE, and Fiser A. M4T: a comparative protein structure modeling server. Nucleic Acids Res 35: W363-W368, 2007.
15. Flint J and Eskin E. Genome-wide association studies in mice. Nat Rev Genet 13: 807-817, 2012.
16. Frazer KA, Eskin E, Kang HM, Bogue MA, Hinds DA, Beilharz EJ, Gupta RV, Montgomery J, Morenzoni MM, Nilsen GB, Pethiyagoda CL, Stuve LL, Johnson FM, Daly MJ, Wade CM, and Cox DR. A sequence-based variation map of 8.27 million SNPs in inbred mouse strains. Nature 448: 1050-1053, 2007.
17. Fukushima-Uesaka H, Saito Y, Maekawa K, Kamatani N, Kajio H, Kuzuya N, Noda M, Yasuda K, and Sawada J. Genetic variations and haplotype structures of transcriptional factor Nrf2 and its cytosolic reservoir protein Keap1 in Japanese. Drug Metab Pharmacokinet 22: 212-219, 2007.
18. Glover JN and Harrison SC. Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 373: 257-261, 1995.
19. Hanada N, Takahata T, Zhou Q, Ye X, Sun R, Itoh J, Ishiguro A, Kijima H, Mimura J, Itoh K, Fukuda S, and Saijo Y. Methylation of the KEAP1 gene promoter region in human colorectal cancer. BMC Cancer 12: 66, 2012.
20. Hudak BB, Zhang LY, and Kleeberger S.R. Inter-strain variation in susceptibility to hyperoxic injury of murine airways. Pharmacogenetics 3: 135-143, 1993.
21. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, and Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236: 313-322, 1997.
22. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, and Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13: 76-86, 1999.
23. Jacob CO, Eisenstein M, Dinauer MC, Ming W, Liu Q, John S, Quismorio FP, Jr., Reiff A, Myones BL, Kaufman KM, McCurdy D, Harley JB, Silverman E, Kimberly RP, Vyse TJ, Gaffney PM, Moser KL, Klein-Gitelman M, Wagner-Weiner L, Langefeld CD, Armstrong DL, and Zidovetzki R. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci USA 109: E59-E67, 2012.
24. Joosten PH, Hol FA, van Beersum SE, Peters H, Hamel BC, Afink GB, van Zoelen EJ, and Mariman EC. Altered regulation of platelet-derived growth factor receptor-alpha gene-transcription in vitro by spina bifida-associated mutant Pax1 proteins. Proc Natl Acad Sci USA 95: 14459-14463, 1998.
25. Khor TO, Huang Y, Wu TY, Shu L, Lee J, and Kong AN. Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation. Biochem Pharmacol 82: 1073-1078, 2011.
26. Kim YR, Oh JE, Kim MS, Kang MR, Park SW, Han JY, Eom HS, Yoo NJ, and Lee SH. Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. J Pathol 220: 446-451, 2010.
27. Kirby A, Kang HM, Wade CM, Cotsapas C, Kostem E, Han B, Furlotte N, Kang EY, Rivas M, Bogue MA, Frazer KA, Johnson FM, Beilharz EJ, Cox DR, Eskin E, and Daly MJ. Fine mapping in 94 inbred mouse strains using a highdensity haplotype resource. Genetics 185: 1081-1095, 2010.
28. Kurokawa H, Motohashi H, Sueno S, Kimura M, Takagawa H, Kanno Y, Yamamoto M, and Tanaka T. Structural basis of alternative DNA recognition by Maf transcription factors. Mol Cell Biol 29: 6232-6244, 2009.
29. Lingappan K, Jiang W, Wang L, Couroucli XI, Barrios R, and Moorthy B. Sex-specific differences in hyperoxic lung injury in mice: implications for acute and chronic lung disease in humans. Toxicol Appl Pharmacol 272: 281-290, 2013.
30. Lingappan K, Srinivasan C, Jiang W, Wang L, Couroucli XI, and Moorthy B. Analysis of the transcriptome in hyperoxic lung injury and sex-specific alterations in gene expression. PLoS One 9: e101581, 2014.
31. Maddatu TP, Grubb SC, Bult CJ, and Bogue MA. Mouse phenome database (MPD). Nucleic Acids Res 40: D887-E894, 2012.
32. Marzec JM, Christie JD, Reddy SP, Jedlicka AE, Vuong H, Lanken PN, Aplenc R, Yamamoto T, Yamamoto M, Cho HY, and Kleeberger S.R. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J 21: 2237-2246, 2007.
33. Masuko H, Sakamoto T, Kaneko Y, Iijima H, Naito T, Noguchi E, Hirota T, Tamari M, and Hizawa N. Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes. Int J Chron Obstruct Pulmon Dis 6: 181-189, 2011.
34. Muscarella LA, Barbano R, D'Angelo V, Copetti M, Coco M, Balsamo T, la Torre A, Notarangelo A, Troiano M, Parisi S, Icolaro N, Catapano D, Valori VM, Pellegrini F, Merla G, Carella M, Fazio VM, and Parrella P. Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome. Epigenetics 6: 317-325, 2011.
35. Nichols JL, Gladwell W, Verhein KC, Cho HY, Wess J, Suzuki O, Wiltshire T, and Kleeberger S.R. Genome-wide association mapping of acute lung injury in neonatal inbred mice. FASEB J 28: 2538-2550, 2014.
36. Paz-Elizur T, Krupsky M, Elinger D, Schechtman E, and Livneh Z. Repair of the oxidative DNA damage 8-oxoguanine as a biomarker for lung cancer risk. Cancer Biomark 1: 201-205, 2005.
37. Prows DR, Hafertepen AP, Gibbons WJ, Jr., Winterberg AV, and Nick TG. A genetic mouse model to investigate hyperoxic acute lung injury survival. Physiol Genomics 30: 262-270, 2007.
38. Rangasamy T, Guo J, Mitzner WA, Roman J, Singh A, Fryer AD, Yamamoto M, Kensler TW, Tuder RM, Georas SN, and Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202: 47-59, 2005.
39. Reddy NM, Kleeberger SR, Kensler TW, Yamamoto M, Hassoun PM, and Reddy SP. Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice. J Immunol 182: 7264-7271, 2009.
40. Reddy NM, Suryanarayana V, Kalvakolanu DV, Yamamoto M, Kensler TW, Hassoun PM, Kleeberger SR, and Reddy SP. Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice. J Immunol 183: 4601-4608, 2009.
41. Rupert PB, Daughdrill GW, Bowerman B, and Matthews BW. A new DNA-binding motif in the Skn-1 binding domain-DNA complex. Nat Struct Biol 5: 484-491, 1998.
42. Schwede T, Kopp J, Guex N, and Peitsch MC. SWISSMODEL: an automated protein homology-modeling server. Nucleic Acids Res 31: 3381-3385, 2003.
43. Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, Yamamoto M, and Hirohashi S. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 135: 1358-1368, 1368.e1351-e1354, 2008.
44. Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, Asamura H, Yamamoto M, and Hirohashi S. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci USA 105: 13568-13573, 2008.
45. Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, Herman JG, Baylin SB, Sidransky D, Gabrielson E, Brock MV, and Biswal S. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med 3: e420, 2006.
46. Soding J, Biegert A, and Lupas AN. The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res 33: W244-W248, 2005.
47. Taguchi K, Motohashi H, and Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16: 123-140, 2011.
48. Thimmulappa RK, Scollick C, Traore K, Yates M, Trush MA, Liby KT, Sporn MB, Yamamoto M, Kensler TW, and Biswal S. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. Biochem Biophys Res Commun 351: 883-889, 2006.
49. Tsang S, Sun Z, Luke B, Stewart C, Lum N, Gregory M, Wu X, Subleski M, Jenkins NA, Copeland NG, and Munroe DJ. A comprehensive SNP-based genetic analysis of inbred mouse strains. Mamm Genome 16: 476-480, 2005.
50. von Otter M, Landgren S, Nilsson S, Celojevic D, Bergstrom P, Hakansson A, Nissbrandt H, Drozdzik M, Bialecka M, Kurzawski M, Blennow K, Nilsson M, Hammarsten O, and Zetterberg H. Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease. BMC Med Genet 11: 36, 2010.
51. Wade CM, Kulbokas EJ, 3rd, Kirby AW, Zody MC, Mullikin JC, Lander ES, Lindblad-Toh K, and Daly MJ. The mosaic structure of variation in the laboratory mouse genome. Nature 420: 574-578, 2002.
52. Wang R, An J, Ji F, Jiao H, Sun H, and Zhou D. Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues. Biochem Biophys Res Commun 373: 151-154, 2008.
53. Ware LB and Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
54. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, Cawley S, Chiaromonte F, Chinwalla AT, Church DM, Clamp M, Clee C, Collins FS, Cook LL, Copley RR, Coulson A, Couronne O, Cuff J, Curwen V, Cutts T, Daly M, David R, Davies J, Delehaunty KD, Deri J, Dermitzakis ET, Dewey C, Dickens NJ, Diekhans M, Dodge S, Dubchak I, Dunn DM, Eddy SR, Elnitski L, Emes RD, Eswara P, Eyras E, Felsenfeld A, Fewell GA, Flicek P, Foley K, Frankel WN, Fulton LA, Fulton RS, Furey TS, Gage D, Gibbs RA, Glusman G, Gnerre S, Goldman N, Goodstadt L, Grafham D, Graves TA, Green ED, Gregory S, Guigo R, Guyer M, Hardison RC, Haussler D, Hayashizaki Y, Hillier LW, Hinrichs A, Hlavina W, Holzer T, Hsu F, Hua A, Hubbard T, Hunt A, Jackson I, Jaffe DB, Johnson LS, Jones M, Jones TA, Joy A, Kamal M, Karlsson EK, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520-562, 2002.
55. Wiltshire T, Pletcher MT, Batalov S, Barnes SW, Tarantino LM, Cooke MP, Wu H, Smylie K, Santrosyan A, Copeland NG, Jenkins NA, Kalush F, Mural RJ, Glynne RJ, Kay SA, Adams MD, and Fletcher CF. Genome-wide singlenucleotide polymorphism analysis defines haplotype patterns in mouse. Proc Natl Acad Sci USA 100: 3380-3385, 2003.
56. Winkler DD, Schuermann JP, Cao X, Holloway SP, Borchelt DR, Carroll MC, Proescher JB, Culotta VC, and Hart PJ. Structural and biophysical properties of the pathogenic SOD1 variant H46R/H48Q. Biochemistry 48: 3436-3447, 2009.
57. Yamamoto T, Yoh K, Kobayashi A, Ishii Y, Kure S, Koyama A, Sakamoto T, Sekizawa K, Motohashi H, and Yamamoto M. Identification of polymorphisms in the promoter region of the human NRF2 gene. Biochem Biophys Res Commun 321: 72-79, 2004.
58. Yoo NJ, Kim HR, Kim YR, An CH, and Lee SH. Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology 60: 943-952, 2012.
59. Zhang P, Singh A, Yegnasubramanian S, Esopi D, Kombairaju P, Bodas M, Wu H, Bova SG, and Biswal S. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol Cancer Ther 9: 336-346, 2010.
60. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9: 40, 2008.